MORINI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.102
EU - Europa 1.087
AS - Asia 387
OC - Oceania 1
Totale 2.577
Nazione #
US - Stati Uniti d'America 1.078
FI - Finlandia 321
CN - Cina 317
SE - Svezia 240
IE - Irlanda 205
UA - Ucraina 135
DE - Germania 115
TR - Turchia 54
GB - Regno Unito 27
CA - Canada 24
BE - Belgio 19
IT - Italia 17
SG - Singapore 8
IN - India 5
AT - Austria 4
IR - Iran 3
AU - Australia 1
EE - Estonia 1
ES - Italia 1
FR - Francia 1
NL - Olanda 1
Totale 2.577
Città #
Chandler 222
Dublin 205
Jacksonville 187
Ann Arbor 108
Dearborn 86
Beijing 58
Nanjing 58
Izmir 54
New York 52
Ashburn 50
Princeton 37
San Mateo 29
Shanghai 24
Toronto 23
Jinan 21
Brussels 19
Hebei 19
Bremen 18
Wilmington 18
Hefei 17
Nanchang 17
Des Moines 15
Shenyang 13
Boardman 12
Grafing 12
Kunming 11
Helsinki 10
Tianjin 10
Changsha 9
Houston 9
Seattle 8
Guangzhou 7
Los Angeles 7
Woodbridge 7
Haikou 6
Jiaxing 6
Hangzhou 5
Norwalk 5
Taiyuan 4
Vienna 4
Auburn Hills 3
Augusta 3
Milan 3
Ningbo 3
Parma 3
Sabz 3
Zhengzhou 3
Borås 2
Dallas 2
Fremont 2
Fuzhou 2
Pune 2
Baotou 1
Bari 1
Canberra 1
Charlotte 1
Chengdu 1
Chongqing 1
Dundee 1
Düsseldorf 1
Frankfurt am Main 1
Jinhua 1
La Canada Flintridge 1
Lanzhou 1
London 1
Madison 1
Madrid 1
Mountain View 1
Mumbai 1
New Delhi 1
Piacenza 1
Redmond 1
Stevenage 1
Taizhou 1
Tallinn 1
Turate 1
Wuhan 1
Xian 1
Totale 1.539
Nome #
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 98
Effect of Cl-Substitution on Rooting- or Cytokinin-like Activity of Diphenylurea Derivatives 97
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 92
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 90
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 83
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 80
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 77
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 75
Action of histamine and ofdifferent synthetic P^ receptor stimulants on the isolated gastric fundus of theguinea pig 74
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 73
HPLC detection ofthioperamide from biological samples and its determination in rat blood and brainafter systemic administration 72
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 71
Diheteroarylurea derivatives as adventitious rooting adjuvants in mung bean shoots and M26 apple rootstock. 70
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 70
Antiulcer long-term treatment in chronic ulcer rat 68
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 67
Cytokinin-like activity of N,N'-diphenylureas. N,N'-bis-(2,3-methylenedioxyphenyl)urea and N,N'-bis-(3,4-methylenedioxyphenyl)urea enhance adventitious root formation in apple rootstock M26 (Malus pumila Mill) 67
Heteroarylaminoethyl and heteroarylthioethylimidazoles. Synthesis and H3-receptor affinity 66
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 66
A possible physiological role ofhistamine H^-receptors in rat mesenteric circulation 66
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 66
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 64
H3-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives 63
Biological studies on 1,2-benzisothiazole derivatives. V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation 63
Pharmacological activities of two new histamine analogs 62
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 61
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 61
null 61
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 59
Studio di sostanze analoghe alDimaprit sulla secrezione gastrica "in vitro" 58
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 58
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 58
Rat protein binding and cerebral phospholipid affinity of the H3-receptor antagonist thioperamide 53
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 53
Synthesis and binding assays of H3-receptor ligands. 50
Synthesis of benzisoxazole and benzisothiazole derivatives with potential antitumor activity 49
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 47
null 37
Antipyreticactivity of new compounds 4-(3-oxo-l,2-benzisothiazolin-2-yl)puenyialkanoicacids, their esters, amides and 1,1 dioxide derivatives 33
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 7
Totale 2.585
Categoria #
all - tutte 7.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201973 0 0 0 0 0 0 0 0 0 0 73 0
2019/2020592 85 74 43 9 52 64 84 10 70 28 33 40
2020/2021278 5 41 19 8 40 1 33 1 65 5 58 2
2021/2022206 5 1 4 19 12 16 26 28 10 12 14 59
2022/2023815 100 98 59 53 79 92 17 45 241 5 20 6
2023/2024218 16 27 4 7 17 92 25 11 10 9 0 0
Totale 2.585